Global warming on backburner; vexed financing deal sees light at COP29
Global representatives at a climate conference signed a $300 billion-a-year deal to finance emissions reductions — a move developing nations say falls way.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Global representatives at a climate conference signed a $300 billion-a-year deal to finance emissions reductions — a move developing nations say falls way.
UN Secretary-General António Guterres outlined a three-point plan to limit global temperature rise to 1.5 degrees Celsius by 2030, including new ways to.
An international body of technical experts in the field of food security has issued an alert about an “imminent” and “substantial” likelihood of.
The World Health Organization has for the first time activated its emergency health network in eight countries affected by the mpox outbreak, including.
Exiting plans to combat climate change “fall miles short” of what’s needed to stop global heating from destroying every economy and wrecking billions.
The Earth’s ozone layer may recover fully by 2040, and five years later over the Arctic, if the current policies restricting the production.
Six staff members working for the United Nations Relief and Works Agency for Palestinian refugees were killed in Gaza during Israeli airstrikes on.
Falling global wages, possibly driven by automation and artificial intelligence, will slow the pace of achieving Sustainable Development Goals (SDG) as the 2030.
United Nations Children’s Fund, the world's largest single vaccine buyer, has issued an emergency tender to buy mpox vaccines to fight the rapid.
The US regulatory body has rejected Regeneron Pharmaceuticals, Inc.,’s blood cancer drug as it did not meet the pre-approval standards of the agency.